ADAMTS9 and endothelial dysfunction: In this study, we aimed to evaluate subclinical atherosclerosis in obese patients with CVD risk indicators such as arterial stiffness (assessed by PWV measurement) and CIMT as well as serum biomarkers of endothelial dysfunction such as endocan, ADAMTS7, and ADAMTS9.